Holdings
PFM Health Sciences, LP
As of Sep 30, 2026, PFM Health Sciences, LP reported 73 positions worth US$835M. Largest: Axsome Therapeutics, Inc., United Therapeutics Corporation and Tenet Healthcare Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Axsome Therapeutics, Inc. | 222K | US$41M | +2,506 | Sep 30, 2026 |
| United Therapeutics Corporation | 69,243 | US$37.5M | +19,252 | Sep 30, 2026 |
| Tenet Healthcare Corporation | 127K | US$32.5M | +722 | Sep 30, 2026 |
| Inhibrx Biosciences, Inc. | 320K | US$32.1M | +11,946 | Sep 30, 2026 |
| Eli Lilly and Company | 25,076 | US$29M | −14,182 | Sep 30, 2026 |
| Neurocrine Biosciences, Inc. | 204K | US$29M | −9,071 | Sep 30, 2026 |
| Indivior Pharmaceuticals, Inc. | 742K | US$26.6M | +341K | Sep 30, 2026 |
| State Street SPDR S&P 500 ETF | 32,421 | US$24.7M | new | Sep 30, 2026 |
| BridgeBio Pharma, Inc. | 366K | US$24.1M | +112K | Sep 30, 2026 |
| Thermo Fisher Scientific Inc | 31,985 | US$21.6M | +3,489 | Sep 30, 2026 |